CTLA4 and cancer: Various immunotherapeutic strategies have shown substantial promise in treating a wide range of cancers, predominantly involving immune checkpoint inhibitors like PD1, PD-L1, and CTLA4, antibody-drug couplings, and cancer vaccines (27).